1-12 of 12
Weimin Huang
Close
Sort by
Journal Articles

CD30 Promotes Proliferation Via ERK 1/2 and p38 MAPK Signal Pathways in ABC-Diffuse Large B Cell Lymphoma

Weimin Huang, Xiaolei Wei, Yongqiang Wei, Ru Feng
Journal: Blood
Blood (2021) 138 (Supplement 1): 4337.
https://doi.org/10.1182/blood-2021-146372
Published: 2021
Journal Articles

PKM2 Inhibition Enhances the Sensitivity of Doxorubicin in ABC Diffuse Large B-Cell Lymphoma Cells

Minglang Zhan, Xiaolei Wei, Weimin Huang, Yongqiang Wei, Ru Feng
Journal: Blood
Blood (2021) 138 (Supplement 1): 4336.
https://doi.org/10.1182/blood-2021-146371
Published: 2021
Journal Articles

Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Jingxia Zheng, Zewen Zhang, Qiongzhi Liu, Minglang Zhan, Weimin Huang, Jianbo Liu, Qi Wei, Yongqiang Wei, Ru Feng
Journal: Blood
Blood (2020) 136 (Supplement 1): 31.
https://doi.org/10.1182/blood-2020-139534
Published: 2020
Journal Articles

Levels of N-Terminal Pro-B-Type Natriuretic Peptide Relate to Risk of Infection in Multiple Myeloma Patients

Weimin Huang, Xiaolei Wei, Qi Wei, Yongqiang Wei, Ru Feng
Journal: Blood
Blood (2020) 136 (Supplement 1): 31.
https://doi.org/10.1182/blood-2020-139067
Published: 2020
Journal Articles

Curcumin Enhances the Sensitivity of Bortezomib By Inhibiting NF-Κb in ABC Diffuse Large B-Cell Lymphoma Cells

Xiaolei Wei, PhD, Jialin Song, Yongqiang Wei, PhD, Hong Zeng, Weimin Huang, PhD, Jingxia Zheng, Ru Feng, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5237.
https://doi.org/10.1182/blood-2019-127705
Published: 2019
Journal Articles

Non-Hematologic Therapy Toxicities Correlated with Survival, Drug Discontinuation and Response in Multiple Myeloma Patients: A Retrospective Study

Weimin Huang, PhD, Yongqiang Wei, PhD, Jingxia Zheng, Xiaolei Wei, PhD, Ru Feng, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5496.
https://doi.org/10.1182/blood-2019-126751
Published: 2019
Journal Articles

HIF-1a Regulating the Chemoresistance By Upregulating the Expression of xCT and GCLM in the Diffuse Large B Cell Lymphoma

Yongqiang Wei, PhD, Hong Zeng, Xiaolei Wei, PhD, Weimin Huang, PhD, Jialin Song, Jingxia Zheng, Ru Feng, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5236.
https://doi.org/10.1182/blood-2019-127612
Published: 2019
Journal Articles

PKM2 Expression Is Associated with Favorable Outcome in Patients with Diffuse Large B-Cell Lymphoma

Yongqiang Wei, MD, Xiaolei Wei, Jialin Song, Weimin Huang, Hong Zeng, Jingxia Zheng, Qi Wei, Ru Feng, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5319.
https://doi.org/10.1182/blood-2018-99-112849
Published: 2018
Journal Articles

Albumin Improves Stratification in the Low IPI Risk Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Yongqiang Wei, MD, Weimin Huang, Jialin Song, Hong Zeng, Jingxia Zheng, Qi Wei, Ru Feng, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5412.
https://doi.org/10.1182/blood-2018-99-112824
Published: 2018
Journal Articles

Beta-2 Microglobulin Improves the IPI Risk Stratification in Patients with Diffuse Large B-Cell Lymphoma

Yongqiang Wei, MD, Xiaolei Wei, Weimin Huang, Jialin Song, Qi Wei, MD, Ru Feng, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5233.
https://doi.org/10.1182/blood.V130.Suppl_1.5233.5233
Published: 2017
Journal Articles

Low Serum Albumin Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Yongqiang Wei, MD, Weimin Huang, Jialin Song, Qi Wei, MD, Ru Feng, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5237.
https://doi.org/10.1182/blood.V130.Suppl_1.5237.5237
Published: 2017
Journal Articles

NCCN-IPI Is Superior to aaIPI and IPI in Predicting Survival of DLBCL in the Rituximab Era

Yongqiang Wei, Yuankun Zhang, Xiaoxiao Hao, Xiaolei Wei, Weimin Huang, Ru Feng, MD
Journal: Blood
Blood (2016) 128 (22): 1872.
https://doi.org/10.1182/blood.V128.22.1872.1872
Published: 2016